PROVIDER PROFILE · NPI 1548226558

Matthew JerlesM.D.

OtolaryngologyMacon, GAI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

879

Unique beneficiaries

—

Total services

951

Distinct HCPCS

Medicare payment

$69K

Peer benchmark

Total Medicare services vs. 300 Otolaryngology providers in GA — top quintile (cohort median 955).

PRESCRIBING · PART D · 2024

Total Rx claims

984

Beneficiaries

—

Total drug cost

$22K

Distinct drugs

Brand share

9.5%

Top prescribed drugs

Azelastine Hcl219 claims

Fluticasone Propionate183 claims

Omeprazole137 claims

Famotidine56 claims

Fluocinolone Acetonide Oil55 claims

QUALITY · MIPS · 2024

Final MIPS score

99.3

Quality

98.6

Cost

0.0

Improvement activities

40.0

Promoting interop.

100.0

Payment adjustment

1.02%

Individual

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$15

Payment records

By payment type

Food and Beverage$15

Top paying entities

Food and Beverage$15

REFERRAL NETWORK

Where Matthew Jerles's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 6 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
THE MEDICAL CENTER OF CENTRAL GEORGIA INC	91	212
Laboratory Corporation Of America Holdings Clinical Laboratory · Birmingham, AL	44	89
John Newman Otolaryngology · Macon, GA	15	30
Bradley Ebel Diagnostic Radiology · Macon, GA	14	24
SOLSTAS LAB PARTNERS GROUP LLC	14	35
ROBINSON, ELIZABETH	11	12

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history